Tonix Pharmaceuticals Holding Corp (FRA:TPM0) Stock News, Headlines & Updates
Tonix Pharmaceuticals Holding Corp Stock News from GuruFocus
- 1
Aug 26, 2024
Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix's Mpox Vaccine, TNX-801
Marketwired • 6:00am
Aug 24, 2024
Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency
ACCESSWIRE • 7:00pm
Aug 23, 2024
Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency
ACCESSWIRE • 7:00am
Aug 21, 2024
Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS)
Marketwired • 6:00am
Aug 20, 2024
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication
Marketwired • 6:00am
Aug 19, 2024
Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights
Marketwired • 5:00am
Aug 16, 2024
Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency
Marketwired • 6:00am
Aug 13, 2024
Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit
Marketwired • 7:00am
Aug 12, 2024
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain
Marketwired • 7:00am
Aug 01, 2024
FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate
ACCESSWIRE • 7:00am
Jul 31, 2024
Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmyaâ„¢
Marketwired • 7:00am
Jul 30, 2024
Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain
Marketwired • 7:00am
Jul 25, 2024
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
Marketwired • 8:00am
Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmyaâ„¢ for Fibromyalgia
Marketwired • 7:00am
Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral
ACCESSWIRE • 11:00pm
Jul 24, 2024
Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral
ACCESSWIRE • 7:00am
Jul 17, 2024
Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025
ACCESSWIRE • 11:00am
Jul 10, 2024
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
Marketwired • 4:00pm
Jul 09, 2024
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
Marketwired • 9:00am
Jul 08, 2024
Tonix Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire • 5:00pm
Tonix Pharmaceuticals Announces Proposed Public Offering
Marketwired • 4:00pm
Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmyaâ„¢ for the Management of Fibromyalgia
Marketwired • 7:00am
Jul 01, 2024
Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program
Marketwired • 7:00am
Jun 28, 2024
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
Marketwired • 4:00pm
Jun 27, 2024
Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering
Marketwired • 8:00am
Jun 26, 2024
Tonix Pharmaceuticals Announces Proposed Public Offering
Marketwired • 4:00pm
Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
Marketwired • 3:00pm
Jun 25, 2024
Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024
Marketwired • 7:00am
Jun 20, 2024
Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmyaâ„¢ for the Management of Fibromyalgia
Marketwired • 7:00am
Jun 18, 2024
Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS)
Marketwired • 7:00am
Jun 17, 2024
Tonix Pharmaceuticals Presented Poster of Tonmyaâ„¢ for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024
Marketwired • 7:00am
Jun 13, 2024
Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering
Marketwired • 4:00pm
Jun 12, 2024
Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
Marketwired • 8:00am
Jun 11, 2024
Tonix Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire • 5:00pm
Tonix Pharmaceuticals Announces Proposed Public Offering
Marketwired • 5:00pm
Jun 06, 2024
Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split
Marketwired • 10:00am
Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024
Marketwired • 7:00am
Jun 05, 2024
Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024
Marketwired • 7:00am
Jun 03, 2024
Tonix Pharmaceuticals Presented New Data on Tonmyaâ„¢ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting
Marketwired • 7:00am
May 30, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news